198 related articles for article (PubMed ID: 26134001)
1. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
Nowak-Sliwinska P; Clavel CM; Păunescu E; te Winkel MT; Griffioen AW; Dyson PJ
Mol Pharm; 2015 Aug; 12(8):3089-96. PubMed ID: 26158308
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs.
Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA
Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459
[TBL] [Abstract][Full Text] [Related]
5. The antiangiogenic properties of sulfated β-cyclodextrins in anticancer formulations incorporating 5-fluorouracil.
Watson CA; Vine KL; Locke JM; Bezos A; Parish CR; Ranson M
Anticancer Drugs; 2013 Aug; 24(7):704-14. PubMed ID: 23695012
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
Du GJ; Lin HH; Xu QT; Wang MW
Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity.
Yao Z; Wu H; Zhang S; Du Y
Carbohydr Polym; 2014 Jan; 101():359-67. PubMed ID: 24299784
[TBL] [Abstract][Full Text] [Related]
9. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
[TBL] [Abstract][Full Text] [Related]
11. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
12. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
13. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
Beedie SL; Peer CJ; Pisle S; Gardner ER; Mahony C; Barnett S; Ambrozak A; Gütschow M; Chau CH; Vargesson N; Figg WD
Mol Cancer Ther; 2015 Oct; 14(10):2228-37. PubMed ID: 26269604
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
16. Preparation, antiangiogenic and antitumoral activities of the chemically sulfated glucan from Phellinus ribis.
Liu Y; Liu Y; Jiang H; Xu L; Cheng Y; Wang PG; Wang F
Carbohydr Polym; 2014 Jun; 106():42-8. PubMed ID: 24721049
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
18. CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity.
Vu HN; Miller WJ; O'Connor SA; He M; Schafer PH; Payvandi F; Muller GW; Stirling DI; Libutti SK
J Surg Res; 2010 Nov; 164(1):116-25. PubMed ID: 19726061
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
20. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]